Windtree Therapeutics Inc (NASDAQ:WINT)’s traded shares stood at 92.8 million during the latest session, with the company’s beta value hitting 0.82. At the last check today, the stock’s price was $2.83, to imply an increase of 67.46% or $1.14 in intraday trading. The WINT share’s 52-week high remains $737.43, putting it -25957.6% down since that peak but still an impressive 42.76% since price per share fell to its 52-week low of $1.62. The company has a valuation of $1.98M, with an average of 0.11 million shares in intraday trading volume over the past 10 days and average of 350.17K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Windtree Therapeutics Inc (WINT), translating to a mean rating of 3.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give WINT a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -39.
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
After registering a 67.46% upside in the latest session, Windtree Therapeutics Inc (WINT) has traded red over the past five days. The 5-day price performance for the stock is 37.71%, and -44.13% over 30 days. With these gigs, the year-to-date price performance is -83.80%. Short interest in Windtree Therapeutics Inc (NASDAQ:WINT) saw shorts transact 82996.0 shares and set a 0.29 days time to cover.
WINT Dividends
Windtree Therapeutics Inc has its next earnings report out on 2024-Nov-25. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Windtree Therapeutics Inc insiders hold 0.07% of total outstanding shares, with institutional holders owning 1.77% of the shares at 1.77% float percentage. In total, 1.77% institutions holds shares in the company.
We also have Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Windtree Therapeutics Inc (WINT) shares. Going by data provided on Dec 31, 2024 , Fidelity Extended Market Index Fund holds roughly 1.18 shares. This is just over 0.00% of the total shares, with a market valuation of $3429.0. Data from the same date shows that the other fund manager holds a little less at 46.0, or 0.00% of the shares, all valued at about 133.0.
